𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

✍ Scribed by Tadeusz Dębniak; Bohdan Górski; Rodney J. Scott; Cezary Cybulski; Krzysztof Mędrek; Elzbieta Zowocka; Grzegorz Kurzawski; Boguslaw Dębniak; Józef Kadny; Stanislawa Bielecka-Grzela; Romuald Maleszka; Jan Lubiński

Publisher
John Wiley and Sons
Year
2004
Tongue
French
Weight
75 KB
Volume
110
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The CDKN2A/ARF genes have been associated with increased risk of malignant melanoma (MM) in families with multiple members affected by disease and in families characterized by the constellation of breast cancer and MM. The exact contribution of CDKN2A/ARF to disease risk remains poorly characterized, especially in diverse populations. In this report, the contribution of CDKN2A/ARF germline mutations and large rearrangements to disease in Polish familial MM (FMM) and aggregations of breast cancer and MM were assessed using a strategy that included genomic sequencing, restriction fragment length polymorphism and multiplex ligation‐dependent probe amplification. We examined 16 FMM cases (group 1), 44 MM probands with a cancer family aggregation (CFA) that included at least one breast cancer (group 2) and 22 breast cancer probands with CFA and MM (group 3). The results revealed a paucity of mutations in CDKN2A/ARF, suggesting that in the Polish population this gene does not contribute significantly to either FMM or MM within the context of CFA. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Identification of modifier genes for cut
Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations
✍ Xiaohong Rose Yang; Ruth M. Pfeiffer; William Wheeler; Meredith Yeager; Stephen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 86 KB

## Abstract __CDKN2A__ is a major susceptibility gene for cutaneous malignant melanoma (CMM), but the variable penetrance and clinical manifestations among mutation carriers suggest the existence of modifier factors. The goal of this study was to identify modifier genes for CMM in CMM‐prone familie

Screening of germline mutations in the C
Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic-based population study
✍ Anton Platz; Johan Hansson; Ulrik Ringborg 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 61 KB 👁 2 views

Germline mutations within the CDKN2A gene, coding for the cyclin-dependent kinase inhibitor p16, have been detected by screening in 8% of Swedish families with an inheritance of cutaneous melanoma (FMM) and dysplastic nevus syndrome (DNS). Contrastingly, the closely related gene CDKN2B had no diseas

Mutation analysis of the BRCA1 and BRCA2
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease
✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi